Vikki Velasquez is a researcher and writer who has managed, coordinated, and directed various community and nonprofit organizations. She has conducted in-depth research on social and economic issues ...

In a recent study investigating the effects of prostaglandin E1 (PGE1) on reducing inspired oxygen concentration during one-lung ventilation (OLV), several key findings and outcomes were identified.

Please provide your email address to receive an email when new articles are posted on . Researchers assessed high-flow nasal therapy in two sequences. The changes in dyspnea and respiratory drive with ...

Acute respiratory distress syndrome is a significant complication in critical care patients. COVID-19 (C19)-associated severe respiratory failure is related to it, and d-dimer rise predicts a worse ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

A combined ratio under 100% indicates an insurance firm's underwriting profitability. A good combined ratio is usually below 100%, with the industry average around 97.5%. Combined ratio plus ...

CAPE ratio calculates long-term valuation by averaging 10 yrs of inflation-adjusted earnings. High CAPE ratios suggest potential overvaluation and future poor returns, low CAPE indicates good buys.

The following is a summary of “Prognostic value of PaO2/FiO2 ratio in predicting clinical outcomes in COVID-19 patients,” published in the June 2024 issue of Critical Care by Canto-Costal et al.

The Golden Ratio (GR), often denoted by the Greek letter phi (Φ), is a mathematical ratio commonly found in nature, art, and architecture. This irrational number, approximately equal to 1.618, has ...

Introduction The use of fibrinolytic therapy has been proposed in severe acute respiratory distress syndrome (ARDS). During the COVID-19 pandemic, anticoagulation has received special attention due to ...

ABSTRACT: Background: Recombinant human soluble thrombomodulin (rhTM) was approved for the treatment of disseminated intravascular coagulation in Japan, and rhTM has anti-inflammatory effects.